Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 3
1996 4
1997 4
1998 4
2000 5
2001 4
2002 1
2004 1
2006 2
2014 1
2016 4
2017 4
2018 4
2019 6
2020 13
2021 6
2022 9
2023 5
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Obesity and contraceptive use: impact on cardiovascular risk.
Rosano GMC, Rodriguez-Martinez MA, Spoletini I, Regidor PA. Rosano GMC, et al. Among authors: regidor pa. ESC Heart Fail. 2022 Dec;9(6):3761-3767. doi: 10.1002/ehf2.14104. Epub 2022 Sep 14. ESC Heart Fail. 2022. PMID: 36103980 Free PMC article. Review.
Bone health in estrogen-free contraception.
Hadji P, Colli E, Regidor PA. Hadji P, et al. Among authors: regidor pa. Osteoporos Int. 2019 Dec;30(12):2391-2400. doi: 10.1007/s00198-019-05103-6. Epub 2019 Aug 24. Osteoporos Int. 2019. PMID: 31446440 Free PMC article. Review.
The drospirenone (DRSP)-only pill: clinical implications in the daily use.
Kubba A, Gemzell-Danielsson K, Palacios S, Wiegratz I, Grandi G, Colli E, Regidor PA. Kubba A, et al. Among authors: regidor pa. Eur J Contracept Reprod Health Care. 2023 Feb;28(1):36-43. doi: 10.1080/13625187.2022.2164186. Eur J Contracept Reprod Health Care. 2023. PMID: 36724207 Free article. Review.
A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg.
Biskupska-Bodova K, Sójka-Kupny J, Nyirády T, Burke AE, Angulo A, Regidor PA. Biskupska-Bodova K, et al. Among authors: regidor pa. Eur J Contracept Reprod Health Care. 2025 Feb;30(1):3-12. doi: 10.1080/13625187.2024.2398433. Epub 2024 Sep 16. Eur J Contracept Reprod Health Care. 2025. PMID: 39279689 Free article. Clinical Trial.
88 results